Schwab Andrew J.
Skye Bioscience, Inc. · Director
Schwab Andrew J. is listed in filings as Director at Skye Bioscience, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2026, including sale activity. Recent filings connect the profile to Skye Bioscience, Inc. (SKYE) and CAMP4 Therapeutics Corporation (CAMP). The current snapshot covers public activity from Sep 13, 2024 to Apr 2, 2026. Reported amounts are shown as $46.1K to $4.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $209k58.6k shares | SellAug 21, 2025 | $3.57 | $0.6493 | |
| $8.3k2.3k shares | SellAug 21, 2025 | $3.57 | $0.6493 | |
| $47979 shares | SellSep 13, 2024 | $6.06 | $0.6493 | |
| $71k11.8k shares | SellSep 13, 2024 | $6.06 | $0.6493 | |
| $12k2k shares | SellSep 13, 2024 | $6.06 | $0.6493 | |
| $1M214.6k shares | SellSep 11, 2024 | $6.60 | $0.6493 | |
| $241k36.5k shares | SellSep 11, 2024 | $6.60 | $0.6493 | |
| $9.5k1.4k shares | SellSep 11, 2024 | $6.60 | $0.6493 |